Huntington's disease: nearly four decades of human molecular genetics

被引:19
|
作者
Gusella, James F. [1 ,2 ,3 ]
Lee, Jong-Min [1 ,2 ,4 ]
MacDonald, Marcy E. [1 ,2 ,4 ]
机构
[1] Massachusetts Gen Hosp, Ctr Genom Med, Mol Neurogenet Unit, Boston, MA 02114 USA
[2] Broad Inst MIT & Harvard, Med & Populat Genet Program, Cambridge, MA 02142 USA
[3] Harvard Med Sch, Blavatnik Inst, Dept Genet, Boston, MA 02115 USA
[4] Harvard Med Sch, Dept Neurol, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
NEURONAL INTRANUCLEAR INCLUSIONS; CAG REPEAT INSTABILITY; TRINUCLEOTIDE REPEAT; SOMATIC INSTABILITY; EMBRYONIC LETHALITY; TRIPLET REPEAT; EXON-1; PROTEIN; HD GENE; ONSET; EXPANSION;
D O I
10.1093/hmg/ddab170
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Huntington's disease (HD) is a devastating neurogenetic disorder whose familial nature and progressive course were first described in the 19th century but for which no disease-modifying treatment is yet available. Through the active participation of HD families, this disorder has acted as a flagship for the application of human molecular genetic strategies to identify disease genes, understand pathogenesis and identify rational targets for development of therapies.
引用
收藏
页码:R254 / R263
页数:10
相关论文
共 50 条
  • [41] Correlative light and electron microscopy suggests that mutant huntingtin dysregulates the endolysosomal pathway in presymptomatic Huntington's disease
    Zhou, Ya
    Peskett, Thomas R.
    Landles, Christian
    Warner, John B.
    Sathasivam, Kirupa
    Smith, Edward J.
    Chen, Shu
    Wetzel, Ronald
    Lashuel, Hilal A.
    Bates, Gillian P.
    Saibil, Helen R.
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2021, 9 (01)
  • [42] Brain Microbiota in Huntington's Disease Patients
    Alonso, Ruth
    Pisa, Diana
    Carrasco, Luis
    FRONTIERS IN MICROBIOLOGY, 2019, 10
  • [43] Clinical Review of Juvenile Huntington's Disease
    Oosterloo, Mayke
    Touze, Alexiane
    Byrne, Lauren M.
    Achenbach, Jannis
    Aksoy, Hande
    Coleman, Annabelle
    Lammert, Dawn
    Nance, Martha
    Nopoulos, Peggy
    Reilmann, Ralf
    Saft, Carsten
    Santini, Helen
    Squitieri, Ferdinando
    Tabrizi, Sarah
    Burgunder, Jean-Marc
    Quarrell, Oliver
    JOURNAL OF HUNTINGTONS DISEASE, 2024, 13 (02) : 149 - 161
  • [44] Hereditary chorea - what else to consider when the Huntington's disease genetics test is negative?
    Malek, N.
    Newman, E. J.
    ACTA NEUROLOGICA SCANDINAVICA, 2017, 135 (01): : 25 - 33
  • [45] Comparison of the Huntington's Disease like 2 and Huntington's Disease Clinical Phenotypes
    Anderson, David G.
    Ferreira-Correia, Aline
    Rodrigues, Filipe B.
    Aziz, N. Ahmad
    Carr, Jonathan
    Wild, Edward J.
    Margolis, Russell L.
    Krause, Amanda
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2019, 6 (04): : 302 - 311
  • [46] Human embryonic stem cell models of Huntington disease
    Niclis, J. C.
    Trounson, A. O.
    Dottori, M.
    Ellisdon, A. M.
    Bottomley, S. P.
    Verlinsky, Y.
    Cram, D. S.
    REPRODUCTIVE BIOMEDICINE ONLINE, 2009, 19 (01) : 106 - 113
  • [47] Molecular genetics of Parkinson's disease: Contributions and global trends
    Funayama, Manabu
    Nishioka, Kenya
    Li, Yuanzhe
    Hattori, Nobutaka
    JOURNAL OF HUMAN GENETICS, 2023, 68 (03) : 125 - 130
  • [48] Somatic CAG Repeat Stability in a Transgenic Sheep Model of Huntington's Disease
    Handley, Renee R.
    Reid, Suzanne J.
    Burch, Zoe
    Jacobsen, Jessie C.
    Gillis, Tammy
    Correia, Kevin
    Rudiger, Skye R.
    McLaughlin, Clive J.
    Bawden, C. Simon
    MacDonald, Marcy E.
    Wheeler, Vanessa C.
    Snell, Russell G.
    JOURNAL OF HUNTINGTONS DISEASE, 2024, 13 (01) : 33 - 40
  • [49] Rehabilitation in Huntington's Disease
    Rollnik, J. D.
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2015, 83 (06) : 334 - 343
  • [50] Mitophagy in Huntington's disease
    Sonsky, I
    Vodicka, P.
    Kepkova, K. Vodickova
    Hansikova, H.
    NEUROCHEMISTRY INTERNATIONAL, 2021, 149